The augmented anti-tumour effects could be due to the efficient cellular uptake of the siRNA/NPs complexes and the early release of the siRNA from the endosome, thereby silencing the expression of EGFR genes and inducing the apoptosis in the treated cells [91,92]. Here, EGFR is linked to neoplasm.